432 filings
Page 8 of 22
8-K
kb5xio7asodjl qa
13 Nov 19
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2019 Financial Results
6:10am
25-NSE
elc9psei7
8 Nov 19
Exchange delisting
4:34pm
8-K
ks5walu z4o5m3
25 Oct 19
Soleno Therapeutics Announces Pricing of $13.4 Million Public Offering of Common Stock
4:03pm
424B5
wyhyz5y96 p2vuu
25 Oct 19
Prospectus supplement for primary offering
12:00am
424B5
tzwxk3jl 3s
22 Oct 19
Prospectus supplement for primary offering
4:24pm
8-K
o75wljxx4s78sd
22 Oct 19
Soleno Therapeutics Announces Proposed Public Offering of Common Stock
4:06pm
8-K
lrjdy76ook 4ju
30 Sep 19
Completion of Acquisition or Disposition of Assets
6:13am
8-K
685eglev q84gb
7 Aug 19
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2019
4:06pm
EFFECT
7v5ycs k8c72k7d9cz
24 Jul 19
Notice of effectiveness
12:15am
CORRESP
pp3qafn8aycravl
22 Jul 19
Correspondence with SEC
12:00am
UPLOAD
jyfyxsg
18 Jun 19
Letter from SEC
12:00am
8-K
arfffak2xpvi43ckvah
12 Jun 19
Soleno Therapeutics Announces Appointment of Veteran Industry Executive Birgitte Volck, M.D., Ph.D., to Board of Directors
4:31pm
S-3
p2p5t070dxjb2zi3ksc6
11 Jun 19
Shelf registration
5:05pm
8-K
1qqr596n5dvh26lu lfy
13 May 19
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2019 Financial Results
8:31am
8-K
lzp pqvia77jh
29 Apr 19
Soleno Therapeutics Announces Appointment of Industry Veteran Gwen A. Melincoff to Board of Directors
4:03pm
DEFA14A
vifua p28kwi5rz9
29 Apr 19
Additional proxy soliciting materials
6:20am